149 related articles for article (PubMed ID: 8953129)
1. Failure of the war to the knife against antiphospholipid antibodies by conventional immunosuppressive therapy in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Schinco PC; Montaruli B
Clin Nephrol; 1996 Nov; 46(5):356. PubMed ID: 8953129
[No Abstract] [Full Text] [Related]
2. Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC?
Hess EV
J Rheumatol; 1998 Feb; 25(2):200-2. PubMed ID: 9489806
[No Abstract] [Full Text] [Related]
3. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
Harten P
Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
[No Abstract] [Full Text] [Related]
4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid antibodies and neurological disorders. Types and mechanisms].
Viñets C; Montiel I; González MJ; Antem M
Rev Neurol; 1996 Oct; 24(134):1224-8. PubMed ID: 8983718
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?
Laskin CA; Clark CA; Spitzer KA
Rheum Dis Clin North Am; 2005 May; 31(2):255-72, vi. PubMed ID: 15922145
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
8. Do immunosuppressives upregulate antiphospholid antibodies?
Korkmaz C
J Rheumatol; 2009 Feb; 36(2):447-8; author reply 448-9. PubMed ID: 19208575
[No Abstract] [Full Text] [Related]
9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
[TBL] [Abstract][Full Text] [Related]
11. Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies.
de Larrañaga G; Forastiero R; Carreras LO; Zala N; Guzman L; Alonso B
Thromb Haemost; 1999 Feb; 81(2):317-8. PubMed ID: 10064016
[No Abstract] [Full Text] [Related]
12. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.
Tincani A; Bazzani C; Zingarelli S; Lojacono A
Semin Thromb Hemost; 2008 Apr; 34(3):267-73. PubMed ID: 18720306
[TBL] [Abstract][Full Text] [Related]
13. The role of antiphospholipid antibodies in coronary artery disease in juvenile systemic lupus erythematosus.
Falcini F; Ermini M; Taccetti G
J Rheumatol; 1995 Jul; 22(7):1438-9. PubMed ID: 7562794
[No Abstract] [Full Text] [Related]
14. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thrombophilic syndromes.
Greaves M
Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
[No Abstract] [Full Text] [Related]
16. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
18. Pediatric antiphospholipid antibodies and antiphospholipid syndrome.
Hunt BJ
Semin Thromb Hemost; 2008 Apr; 34(3):274-81. PubMed ID: 18720307
[TBL] [Abstract][Full Text] [Related]
19. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
[TBL] [Abstract][Full Text] [Related]
20. [Oxidized low-density lipoprotein antibodies in systemic lupus erythematosus: their connection with phospholipid antibodies].
Nasonov EL; Popkova TV; Efremov EE; Reshetniak TM; Kameneva AM; Aleksandrova EN; Fomicheva OA; Alekberova ZS
Klin Med (Mosk); 1997; 75(9):49-52. PubMed ID: 9432544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
